Order RYANODEX® Today!

RYANODEX is available to order through several major healthcare distribution centers*

To place an order through one of these distributors, please contact customer service for more information.

Order Number	Distributor	Customer Service
10144143	AmerisourceBergen (ABC)	844.222.2273
5010343	Cardinal Health (CAH)	800.926.3161
1000022670	Cesar Castillo	787.641.5082
122 – 8846	Henry Schein Medical	866.234.6507
944053	McKesson Medical-Surgical	855.571.2100
3227584	McKesson Specialty Health (McK)	855.625.4677
RYAN250	Medical Purchasing Solutions	888.894.2487
662411	Morris & Dickson (M&D)	800.388.3833

NDC #42367-540-32

*Please check back as we continue to update this page with additional information.

Important Safety Information

RYANODEX® is not a substitute for appropriate supportive measures in the treatment of malignant hyperthermia (MH), including discontinuing use of MH-triggering anesthetic agents, managing the metabolic acidosis, instituting cooling when necessary, and administering diuretics to prevent late kidney injury due to myoglobinuria (the amount of mannitol in RYANODEX® is insufficient to maintain diuresis).

RYANODEX® is associated with skeletal muscle weakness such as loss of grip strength and weakness in the legs, as well as drowsiness, dizziness, dysphagia, dyspnea, and decreased inspiratory capacity. Patients should not be permitted to ambulate without assistance until they have normal strength and balance. Care must be taken to prevent extravasation of RYANODEX® into the surrounding tissue due to the high pH of the reconstituted RYANODEX® suspension and potential for tissue necrosis.

Please see full Prescribing Information.

Indication

RYANODEX® (dantrolene sodium) for injectable suspension is indicated for the treatment of malignant hyperthermia in conjunction with appropriate supportive measures, and for the prevention of malignant hyperthermia in patients at high risk.

Indication and Important Safety Information

VIEW ALL